Brandon Childs, MD
Urology · West Jordan, UTNPI 1659721199
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,875 of the $3,033 with a category attached, or 61.8%. Boston Scientific accounts for 60.4% of it on its own, with 22 other manufacturers making up the rest. That places this record below the midpoint for urology clinicians in UT, where the typical reported total is $3,296.
Across 70 payments — averaging $43.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Calyxo, Inc.$192
- Endo USA, Inc.$156
- Sumitomo Pharma America, Inc.$122
- Laborie Medical Technologies Corp.$93
- Ferring Pharmaceuticals Inc.$80
- plus $558 from 17 others
What the payments were for
- Travel & lodging$1,15838%
- Food & beverage$1,87562%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 21 | $1,832 |
| Calyxo, Inc. | 2 | $192 |
| Endo USA, Inc. | 7 | $156 |
| Sumitomo Pharma America, Inc. | 6 | $122 |
| Laborie Medical Technologies Corp. | 3 | $93 |
| Ferring Pharmaceuticals Inc. | 4 | $80 |
| Astellas Pharma US Inc | 2 | $56 |
| Endo Pharmaceuticals Inc. | 3 | $56 |
| Merck | 2 | $53 |
| AbbVie | 2 | $42 |
| Axonics, Inc. | 2 | $38 |
| Procept Biorobotics Corporation | 2 | $37 |
| Urogen Pharma, Inc. | 1 | $32 |
| Bayer | 1 | $31 |
| Medtronic | 2 | $31 |
| Olympus America Inc. | 2 | $30 |
| Azurity Pharmaceuticals, Inc. | 2 | $29 |
| Intuitive Surgical | 1 | $27 |
| Novo Nordisk | 1 | $26 |
| Dexcom, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Cook Medical LLC | 1 | $16 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,033 in reported general payments places this provider in the 45th percentile of 96 urology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 79 | $43,593 |
| GemtesaVibegron | 28 | $34,763 |
| Estradiol | 80 | $6,134 |
| Methenamine Hippurate | 22 | $3,681 |
| Tamsulosin Hcl | 201 | $2,956 |
| Testosterone Cypionate | 33 | $1,558 |
| Trospium Chloride ErTrospium Chloride | 12 | $1,471 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 65 | $862 |
| Potassium Citrate ErPotassium Citrate | 17 | $732 |
| Gentamicin Sulfate | 35 | $545 |
| Finasteride | 22 | $468 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $281 |
| Cefadroxil | 20 | $158 |
| Indapamide | 14 | $156 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 36 | $134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $56 | $43,59379 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $122 | $34,76328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 96 urology providers in Utah.
Other urology in West Jordan
- Joshua HolyoakWest Jordan$6K
- Steven GangeSlc$1.5M
- William BrantSalt Lake City$290K
- Roscoe NelsonAmerican Fork$152K
- Nathan PursifullAmerican Fork$86K
- Benjamin McCormickSalt Lake City$67K
- Richard MaternSalt Lake City$58K
- Akhil SajiSalt Lake City$49K
- Jeffrey SparenborgProvo$37K
- Daniel SimonRiverton$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.